These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1979661)

  • 21. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF somatostatin increase in patients with early parkinsonian syndrome.
    Espino A; Calopa M; Ambrosio S; Ortolà J; Peres J; Navarro MA
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):189-96. PubMed ID: 8527003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up.
    Koponen H; Reinikainen K; Riekkinen PJ
    Psychol Med; 1990 Aug; 20(3):501-5. PubMed ID: 1978369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
    Jolkkonen J; Hartikainen P; Soikkeli R; Bissette G; Nemeroff C; Riekkinen P
    Neuropeptides; 1991 Jun; 19(2):97-102. PubMed ID: 1682848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
    Whitford C; Candy J; Edwardson J; Perry R
    J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease and dementia: clinical and neurochemical correlations.
    Strittmatter MM; Cramer H
    Neuroreport; 1992 May; 3(5):413-6. PubMed ID: 1378766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
    Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
    Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine lowering effect on CSF somatostatin-like immunoreactivity in temporal lobe epileptics.
    Steardo L; Barone P; Hunnicutt E
    Acta Neurol Scand; 1986 Aug; 74(2):140-4. PubMed ID: 2877537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin infused during acute pancreatitis retains its biological activity.
    Annibale B; Ribaldi S; Anania MC; Stagnitti F; Strom R; Corleto V; Delle Fave G
    Pancreas; 1989; 4(6):674-9. PubMed ID: 2573057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentylenetetrazol-induced convulsions on somatostatin-like immunoreactivity in rat cerebrospinal fluid.
    Pitkänen A; Jolkkonen J; Honkanen KL; Riekkinen P
    Neuropeptides; 1987 Jan; 9(1):19-24. PubMed ID: 2882440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
    Miyazaki K; Funakoshi A; Ibayashi H
    Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
    Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H
    Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of haloperidol on somatostatin-like immunoreactivity in the CSF of Schizophrenic patients.
    Gattaz WF; Rissler K; Gattaz D; Cramer H
    Psychiatry Res; 1986 Jan; 17(1):1-6. PubMed ID: 2868477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 37. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Mazurek MF; Martin JB
    Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Clevens RA; Mazurek MF
    Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric mucosal somatostatin-like immunoreactivity in peptic ulcer.
    Torres AJ; Fernandez-Durango R; Suarez A; Ariznavarreta C; Hernandez F; Cuberes R; Ortega L; Balibrea JL
    Surg Gynecol Obstet; 1987 Apr; 164(4):313-8. PubMed ID: 3563843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin and beta-endorphin levels in cerebrospinal fluid of nonmedicated and medicated patients with epileptic seizures.
    Pitkänen A; Lepola U; Ylinen A; Riekkinen PJ
    Neuropeptides; 1989 Jan; 13(1):9-15. PubMed ID: 2564169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.